MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
29.80
-0.66
-2.17%
After Hours: 29.80 0 0.00% 19:30 09/11 EDT
OPEN
30.83
PREV CLOSE
30.46
HIGH
31.72
LOW
29.68
VOLUME
258.94K
TURNOVER
--
52 WEEK HIGH
39.71
52 WEEK LOW
20.23
MARKET CAP
606.75M
P/E (TTM)
-183.2718
1D
5D
1M
3M
1Y
5Y
1D
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
NASDAQ · 4d ago
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)
TipRanks · 4d ago
Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead
Dow Jones · 5d ago
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High?
NASDAQ · 6d ago
Weekly Report: what happened at ASMB last week (0831-0904)?
Weekly Report · 6d ago
Should You Buy Assembly Biosciences (ASMB) After Golden Cross?
NASDAQ · 09/04 13:55
5 Stocks With Recent Price Strength Buoyed by a Strong August
NASDAQ · 09/04 12:56
Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going
NASDAQ · 09/03 12:55
More
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.